Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
Authors:
- Giovanni TripepiGTGiovanni Tripepi
- Sebastiano CutrupiSCSebastiano Cutrupi
- Lorenzo S. MalatinoLorenzo S. Malatino
- Carmine ZoccaliCarmine Zoccali
- 1 June 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 67 (6) , 2330-2337
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Asymmetrical DimethylarginineCirculation, 2004
- Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,21The interpretation and reporting of the data presented here are the responsibility of the authors, and in no way should be seen as an official policy or interpretation of the United States government.2See Editorial by Orth and Uehlinger, p. 1580.Kidney International, 2003
- The Prognostic Role of Brain Natriuretic Peptides in Hemodialysis PatientsAmerican Journal of Nephrology, 2002
- Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patientsKidney International, 2002
- Diagnostic potential of cardiac natriuretic peptides in dialysis patientsKidney International, 2001
- Inflammation is associated with carotid atherosclerosis in dialysis patientsJournal Of Hypertension, 2000
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Cross-sectional comparison of malnutrition in continuous ambulatory peritoneal dialysis and hemodialysis patientsAmerican Journal of Kidney Diseases, 1995